Clinical Trial Site

Bron 69677

2 studies enrolling now · 8 studies all time

What they study most

ANCA-Associated Vasculitis, ATTR Amyloidosis, Atypical Hemolytic-Uremic Syndrome, End Stage Renal Disease, Genetic Disease, Hereditary Hemorrhagic Telangiectasia, Kidney Diseases, Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Primary Hyperoxaluria Type 3 (PH3)

Studies at this site

• ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) — Recruiting now
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) — Running, not enrolling
• A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 — Completed
• Long Term Extension Study in Patients With Primary Hyperoxaluria — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed